TH51691A - Methods and mixtures for the treatment of lung disease - Google Patents
Methods and mixtures for the treatment of lung diseaseInfo
- Publication number
- TH51691A TH51691A TH1004212A TH0001004212A TH51691A TH 51691 A TH51691 A TH 51691A TH 1004212 A TH1004212 A TH 1004212A TH 0001004212 A TH0001004212 A TH 0001004212A TH 51691 A TH51691 A TH 51691A
- Authority
- TH
- Thailand
- Prior art keywords
- treatment
- lung disease
- mixtures
- methods
- inhibitor
- Prior art date
Links
- 208000019693 Lung disease Diseases 0.000 title claims abstract 4
- 239000000203 mixture Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract 3
- 239000003246 corticosteroid Substances 0.000 claims abstract 3
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 claims 2
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 claims 2
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims 1
- 229960004436 budesonide Drugs 0.000 claims 1
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 1
- 229960000676 flunisolide Drugs 0.000 claims 1
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 229960002117 triamcinolone acetonide Drugs 0.000 claims 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
- 208000006673 asthma Diseases 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
Abstract
DC60 (29/01/44) การประดิษฐ์นี้สัมพันธ์กับการรักษาโรคปอด ดังเช่น โรคปอดอุดตันเรื้อรัง หรือโรคหืดโดย การให้ตัวยับยั้งฟอสฟอไดเอส เทอเรส 4 ในการรวมกันกับคอร์ทิโคสเทียรอยด์ที่แก้อักเสบ การประดิษฐ์นี้สัมพันธ์กับการรักษาโรคปอด ดังเช่น โรคปอดอุดตันเรื้อรัง หรือโรคหืดโดย การให้ตัวยับยั้งฟอสฟอไดเอส เทอเรส 4 ในการรวมกันกับคอร์ทิโคสเทียรอยด์ที่แก้อักเสบ สิทธิบัตรยา DC60 (29/01/44) This invention is associated with the treatment of lung diseases such as chronic obstructive pulmonary disease. Or asthma by The administration of a phosphodesterase 4 inhibitor in combination with anti-inflammatory corticosteroid. The invention is associated with the treatment of lung diseases such as chronic obstructive pulmonary disease. Or asthma by The administration of a phosphodesterase 4 inhibitor in combination with the anti-inflammatory corticosteroid, drug patent.
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH51691A true TH51691A (en) | 2002-06-28 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0200356D0 (en) | Novel use | |
| WO2003000241A3 (en) | Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases | |
| IS6444A (en) | Pyrimidine carboxamide useful for inhibiting PDE4 isotopic enzymes | |
| MXPA02011311A (en) | Novel composition. | |
| PE44995A1 (en) | MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT | |
| JP2007514005A5 (en) | ||
| NO20025220D0 (en) | New procedure | |
| CY1107696T1 (en) | COMBINATION OF EFFECTIVE LOTEPREDNOLIS AND DFHO FOR TREATMENT OF RESPIRATORY DISEASES, ALLERGIC DISEASES, ASTHMA AND COPD | |
| BR0307050A (en) | Compound, pharmaceutical composition, methods for treating prostaglandin d2 mediated diseases, for treating nasal congestion, for treating allergic asthma, and for treating allergic rhinitis, pharmaceutically acceptable salt, and use of a compound or salt | |
| ATE421325T1 (en) | COMBINATION OF METHYLXANTHINE COMPOUNDS AND STEROIDS FOR THE TREATMENT OF CHRONIC RESPIRATORY DISEASES | |
| CO5550426A2 (en) | NOVEDOUS THERAPEUTIC METHOD | |
| WO2005041864A3 (en) | Combination of cyclooxygenase-2 inhibitor and phosphodiesterase 4 inhibitor and method | |
| WO2004082590A3 (en) | A low dose corticosteroid composition | |
| RU2006137717A (en) | [4 - (- AMINOMETHYL-2-fluorophenyl) -PEPERIDIN-1-IL] - (4-BROM-3-METHID-5-PROXYTHIOPHEN-2-IL) -METHANONE HYDROCHLORIDE AS A MASCULAR TRIPTASE INHIBITOR | |
| SE9900833D0 (en) | Novel combination | |
| MXPA03011702A (en) | Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases. | |
| WO2005011594A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2002017894A3 (en) | Pharmaceutical formulation of salmeterol and fluticasone propionate | |
| TH51691A (en) | Methods and mixtures for the treatment of lung disease | |
| SE9900834D0 (en) | Novel combination | |
| BG106748A (en) | Method and compositions for treating pulmonary diseases | |
| WO2005011604A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease | |
| DE602006012332D1 (en) | COMBINATION OF COMPOUNDS WHICH CAN BE USED IN THE TREATMENT OF RESPIRATORY DISEASES, ESPECIALLY IN CHRONIC OBSTRUCTIVE LUNG DISEASE (COPD) AND ASTHMA | |
| WO2005011616A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2005011602A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |